Effect of atorvastatin on level of B-type natriuretic peptide and cardiac function in patients with coronary heart disease and heart failure

Li-fang ZHAO,Pei-zhi MIAO,Qi-hong CHEN,Shui-ming GU

DOI: https://doi.org/10.16138/j.1673-6087.2010.05.004

2010-01-01

Abstract:Objective To observe the effect of atorvastatin on level of B-type natriuretic peptide(BNP)and cardiac function in patients with coronary heart disease(CHD) and heart failure(HF).Methods One hundred and twenty-eight patients with CHD and HF(NYHAⅡ-Ⅲdegree) were randomly divided into atorvastatin A group,atorvastatin B group and control group.All patients were given HF basic treatment.Patients in atorvastatin A group were given additionally atorvastatin 10 mg/d.and in atorvastatin B group 20 mg/d.The plasma level of BNP,serum level of high-sensitivity Creactive protein(hs-CRP) and 6 minutes walking test(6MWT) were determined before treatment and 12 weeks after treatment.The left ventricular ejection fraction(LVEF) was measured by echocardiography.Results The cardiac function,plasma BNP and serum hs-CRP in all three groups improved obviously after 12 weeks treatment.LVEF increased significantly(P<0.01),and BNP and hs-CRP decreased significantly(P<0.01) in the two atorvastatin treated groups when compared with that in control group.Six minutes walking distance of the two atorvastatin treatment groups was significantly greater than that of control group(P<0.05).No significant differences in these parameters were found between the two atorvastatin treatment groups.Conclusions On the basis of basic HF treatment,the addition of small dose of atorvastatn could decrease plasma BNP and serum hs-CRP levels and further improve cardiac function in patients with CHD and HF,and the inhibition of myocardial micro-inflammation might be one of the mechanisms.